Table 1 Demographic and clinical features of 90,281 patients at ART initiation in the Hlabisa and Right to Care cohorts in South Africa
From: Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study
Hlabisa Cohorta | RTC Cohortb | ||
|---|---|---|---|
(n = 21,766) | (n = 69,283) | ||
Gender | % male | 7421 (34.1%) | 25902 (37.4%) |
Age at initiation (years) | <18 | 2092 (9.6%) | 3390 (4.9%) |
18-29 | 6369 (29.3%) | 15470 (22.3%) | |
30-39 | 7294 (33.5%) | 28286 (40.8%) | |
40-49 | 3880 (17.8%) | 15334 (22.1%) | |
> = 50 | 2125 (9.8%) | 6803 (9.8%) | |
Median (IQR) | 33 (26, 41) | 35 (29, 42) | |
CD4 count (cells/mm3) at initiation | 0-49 | 3282 (16.1%) | 15228 (22.0%) |
50-99 | 3220 (15.8%) | 10699 (15.4%) | |
100-199 | 7567 (37.0%) | 19795 (28.6%) | |
200-349 | 4818 (23.6%) | 11346 (16.4%) | |
> = 350 | 1540 (7.5%) | 4178 (6.0%) | |
Missing | 1339 (6.2%) | 8037 (11.6%) | |
Median (IQR) | 152 (78, 226) | 123 (50, 201) | |
Year of ART initiation | 2005 | n/a | 2975 (4.3%) |
2006 | n/a | 5339 (7.7%) | |
2007 | 1963 (9.0%) | 6530 (9.4%) | |
2008 | 3467 (15.9%) | 8612 (12.4%) | |
2009 | 3223 (14.8%) | 10546 (15.2%) | |
2010 | 3723 (17.1%) | 11036 (15.9%) | |
2011 | 4607 (21.2%) | 8325 (12.0%) | |
2012 | 4783 (22.0%) | 6744 (9.7%) | |
2013 | n/a | 5457 (7.9%) | |
2014 | n/a | 3719 (5.4%) |